Grid is committed to advancing our unique strategy to develop better and safer medicines for our patients. This has and will continue to be our sole mission.

Our clinical trial in non-small cell lung cancer is currently enrolling. The trial is registered on the Clinical website.

For further support or questions contact:

Grid Therapeutics
Dr. Edward Patz,

Duke Thoracic Oncology
Phone number (919) 681-4768